Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ABT
NVO
Add up to 3 more stocks
ABT
Abbott Laboratories
-1.24%
$101.81-1.28Delayed quote: Sep 15, 2026, 10:45 AM EDT
Market Cap
$176.18B
52W Range
$81.97 - $137.49
NVO
Novo Nordisk A/S
-2.00%
$42.58-0.87Delayed quote: Sep 15, 2026, 10:45 AM EDT
Market Cap
$189.08B
52W Range
$35.12 - $64.16
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 32.74 | 10.49 |
| Forward P/E | 18.45 | N/A |
| P/B Ratio | 3.45 | 5.61 |
| P/S Ratio | 3.78 | 3.70 |
| P/FCF Ratio | 22.24 | 25.38 |
| EV/EBITDA | 18.71 | 7.77 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 56.8% | 80.6% |
| Operating Margin | 17.0% | 43.1% |
| Net Margin | 11.7% | 35.3% |
| ROE | 10.6% | 53.5% |
| ROA | 5.0% | 19.9% |
| ROIC | 6.1% | 30.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.38 | 0.87 |
| Quick Ratio | 0.97 | 0.66 |
| Debt/Equity | 0.64 | 0.63 |
| Interest Coverage | 23.60 | 30.34 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 2.4% | 4.2% |
| Payout Ratio | 79.7% | 44.3% |
| Yrs of Dividend Growth | 52 | 6 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.